These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 18045203)
1. The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers. Reitz AB; Gupta SK; Huang Y; Parker MH; Ryan RR Med Chem; 2007 Nov; 3(6):543-5. PubMed ID: 18045203 [TBL] [Abstract][Full Text] [Related]
2. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes. Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of ether analogues as potent and selective M2 muscarinic receptor antagonists. Wang Y; Chackalamannil S; Chang W; Greenlee W; Ruperto V; Duffy RA; McQuade R; Lachowicz JE Bioorg Med Chem Lett; 2001 Apr; 11(7):891-4. PubMed ID: 11294385 [TBL] [Abstract][Full Text] [Related]
4. Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. Tayebati SK; Codini M; Gallai V; Mannino F; Parnetti L; Ricci A; Sarchielli P; Amenta F J Neuroimmunol; 1999 Oct; 99(2):224-9. PubMed ID: 10505979 [TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells. Watson N; Daniels DV; Ford AP; Eglen RM; Hegde SS Br J Pharmacol; 1999 May; 127(2):590-6. PubMed ID: 10385263 [TBL] [Abstract][Full Text] [Related]
6. Sulfide analogues as potent and selective M(2) muscarinic receptor antagonists. Wang Y; Chackalamannil S; Hu Z; McKittrick BA; Greenlee W; Ruperto V; Duffy RA; Lachowicz JE Bioorg Med Chem Lett; 2002 Apr; 12(7):1087-91. PubMed ID: 11909724 [TBL] [Abstract][Full Text] [Related]
7. Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs. Noronha-Blob L; Kachur JF J Pharmacol Exp Ther; 1991 Feb; 256(2):562-7. PubMed ID: 1993995 [TBL] [Abstract][Full Text] [Related]
8. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists. Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650 [TBL] [Abstract][Full Text] [Related]
9. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells. Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649 [TBL] [Abstract][Full Text] [Related]
10. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland. Kobayashi F; Yageta Y; Segawa M; Matsuzawa S Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619 [TBL] [Abstract][Full Text] [Related]
11. Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice. Ito Y; Oyunzul L; Yoshida A; Fujino T; Noguchi Y; Yuyama H; Ohtake A; Suzuki M; Sasamata M; Matsui M; Yamada S Eur J Pharmacol; 2009 Aug; 615(1-3):201-6. PubMed ID: 19446545 [TBL] [Abstract][Full Text] [Related]
12. Selective muscarinic antagonists. I. Synthesis and antimuscarinic properties of 4-piperidyl benzhydrylcarbamate derivatives. Naito R; Takeuchi M; Morihira K; Hayakawa M; Ikeda K; Shibanuma T; Isomura Y Chem Pharm Bull (Tokyo); 1998 Aug; 46(8):1274-85. PubMed ID: 9734315 [TBL] [Abstract][Full Text] [Related]
13. Tolterodine--a new bladder-selective antimuscarinic agent. Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560 [TBL] [Abstract][Full Text] [Related]
14. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors. Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767 [TBL] [Abstract][Full Text] [Related]